TRPV4 and glaucoma: Jo et al. showed that TRPV4 controls cell volume, lipid, and calcium signals in nonpigmented and pigmented epithelial cells of the mouse ciliary body, which highlights that TRPV4 can be a promising drug target for the treatment of glaucoma [118].